Streetbeat News

ACHC

Acadia Healthcare Company, Inc.

https://www.acadiahealthcare.com

Industry

Medical - Care Facilities

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.

Open

36.99

Mkt cap

3.5B

Volume

292K

High

37.23

P/E Ratio

12.21

52-wk high

87.77

Low

36.60

Div yield

N/A

52-wk low

36.50

Acadia Healthcare has increased its revenue outlook for 2023 from $2.86B-$2.90B to $2.90B-$2.92B.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 8:52 pm

Acadia Healthcare Co reported Q3 2023 earnings of $0.91 per share, beating the analyst consensus estimate of $0.89 by 2.25%. This is a 13.75% increase from the same period last year. The company also reported quarterly sales of $750.33 million, beating the analyst consensus estimate of $725.31 million by 3.45%. This is a 12.54% increase from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 02, 2023 | 8:30 pm

Acadia Healthcare Co (NASDAQ:ACHC) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $0.89. The company's past performance shows a pattern of beating EPS estimates, which has often led to an increase in share price. However, the company's shares have seen a general decline over the last 52-week period, down by 5.03%.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 3:01 pm

Analysts have provided somewhat bullish ratings for Acadia Healthcare Co (NASDAQ:ACHC) in the last quarter. According to 4 analysts offering 12-month price targets in the last 3 months, Acadia Healthcare Co has an average price target of $90.5, an increase of 2.84% from the previous average price target of $88.00.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 3:01 pm

Cantor Fitzgerald analyst Joseph France has maintained a Neutral rating on Acadia Healthcare Co (NASDAQ:ACHC) and raised the price target from $83 to $85.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 1:11 pm

RBC Capital analyst Ben Hendrix maintains an Outperform rating on Acadia Healthcare Co (NASDAQ:ACHC) and raises the price target from $93 to $99.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 2:13 pm

Credit Suisse analyst A.J. Rice has reiterated an 'Outperform' rating on Acadia Healthcare Co (NASDAQ:ACHC) and maintained a $95 price target.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 12:34 pm

Acadia Healthcare has increased its FY23 revenue outlook from $2.82B-$2.88B to $2.86B-$2.90B, with an adjusted EPS from $3.10-$3.40 to $3.25-$3.50. The estimates were $2.86B and $3.30 respectively.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 8:34 pm

Acadia Healthcare Co (NASDAQ:ACHC) reported Q2 adjusted earnings of $0.92 per share, beating the analyst consensus estimate of $0.86 by 6.98%. The company also reported quarterly sales of $731.34 million, surpassing the analyst consensus estimate of $711.71 million by 2.76%. Both earnings and sales have increased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 8:16 pm

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has formed a joint venture with Nebraska Methodist Health System to build a 96-bed behavioral health hospital in Council Bluffs, Iowa. This partnership will expand Acadia's acute service line into a new state and is the 20th joint venture for Acadia. The new hospital will offer a full range of inpatient and outpatient behavioral healthcare services.

Portfolio Pulse from Happy Mohamed

July 24, 2023 | 8:17 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.